Global Fabry Disease

This study covers the world outlook for orphan disease therapeutics in genetics disorders across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent ...

This study covers the world outlook for Fabry disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of ...

This study covers the world outlook for lysosomal storage diseases treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the c ...

This study covers the world outlook for lysosomal storage diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is o ...

This study covers the world outlook for lysosomal storage diseases therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the ...

The global Fabry disease treatment market was valued at US$ 2.22 Billion in 2024, and is predicted to reach US$ 3.86 Billion by 2030. Fabry disease is a rare genetic disorder caused by a deficiency or malfunction of the enzyme alpha-galactosidase A (α-GAL A). This enzyme is essential for the breakin ...

Fabry Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This report focuses on fabry disease treatment market which is experiencing strong growth. The repo ...

Fabry Disease Market Report by Type (Type 1, Type 2, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2025-2033 The global fabry disease market size reached USD 2.1 Billion in 2024. Looking forward, IMARC Group exp ...

Fabry Disease Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type This report describes the global market size of Fabry Disease Drugs from 2020 to 2024 and its CAGR from 2020 to 2024, and also forecasts its market size to the end of 2 ...

Rare Kidney Diseases Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Target Disease Indications The Rare Kidney Diseases Market is valued at USD 3.9 billion in 2024 growing at a CAGR of 11% during the forecast period 2024-2035. Rare kidney diseases encompass a spectrum of co ...

Enzyme Replacement Therapy Market Size, Trends, Analysis, and Outlook By Product (Agalsidase Beta, Imiglucerase , Velaglucerase Alfa, Idursulfase, Galsulfase, Laronidase, Others), By Disease (Gaucher Disease, Fabry Disease, Pompe Disease, Mucopolysaccharidosis, Exocrine Pancreatic Insufficiency (EPI ...

Enzyme Replacement Therapy Market by Therapeutic Condition (Fabry Disease, Gaucher Disease, Mucopolysaccharidosis), Enzyme Type (Agalsidase Beta, Alglucosidase Alfa, Galsulfase), Route of Administration, End-User - Global Forecast 2024-2030 The Enzyme Replacement Therapy Market size was estimated at ...

Lysosomal Storage Diseases Market by Disease Type (Fabry Diseases, Gaucher's Diseases, Mucopolysaccharidosis), Type of Therapy (Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy), End User - Global Forecast 2024-2030 The Lysosomal Storage Diseases Market size was estimated a ...

Fabry Disease Treatment Market by Treatment Type (Chaperone Treatment, Enzyme Replacement Therapy, Organ-Specific Treatment), Drugs (Agalsidase Beta, Migalastat, Pipeline Drugs), Route of Administration - Global Forecast 2024-2030 The Fabry Disease Treatment Market size was estimated at USD 2.50 bil ...

Global Fabry Disease Drugs Market 2024-2028 The fabry disease drugs market is forecasted to grow by USD 859.06 mn during 2023-2028, accelerating at a CAGR of 7.43% during the forecast period. The report on the fabry disease drugs market provides a holistic analysis, market size and forecast, trends, ...

Global Fabry Disease Treatment Market - 2023-2030 The Global Fabry Disease Treatment Market size reached US$ 1,876.7 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 3,287.2 million by 2030. The global Fabry disease treatment market is expected to exhibit a CAGR of ...

Plant-Based Biologics Market By Product Type (Leaf-based, Seed-Based, Fruit-based, Others), By Source (Carrot, Tobacco, Rice, Duckweed, Others), By Target Disease (Gaucher Disease, Fabry Disease, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031 The global Plant-based biologics m ...

Global Fabry Disease Treatment Market Growth (Status and Outlook) 2023-2029 Fabry disease is a rare X-linked lysosomal storage disorder with a deficiency of alpha galactosidase enzyme resulting in progressive organ dysfunction. This disease is caused by abnormal buildup of a specific fatty matter ca ...

Global Enzyme Replacement Therapy Market Size study & Forecast, by Product (Agalsidase Beta, Imiglucerase, Velaglucerase Alfa, Idursulfase, Galsulfase, Laronidase, Others) by Disease (Gaucher Disease, Fabry Disease, Pompe Disease, Mucopolysaccharidosis, Exocrine Pancreatic Insufficiency (EPI), Other ...

Global Enzyme Replacement Therapy Market - 2022-2029 Market Overview Enzyme Replacement Therapy Market was valued at USD XX million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of 5.1 % during the forecast period (2022-2029). Enzyme Replacement Therapy (ERT) is the tr ...